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a b s t r a c t
The testicular capsule contracts in response to noradrenaline and adrenaline, but the effects of adreno-
ceptor agonists, as for instance clonidine, had not yet been thoroughly evaluated. The testicular capsule
from adult male Wistar rats was isolated and mounted in organ bath and cumulative concen-
tration curves were performed for clonidine and other adrenergic agonists in the absence or presence
of α-adrenoceptors antagonists. The order of potency for agonists (pD2) was clonidine¼adrenaline4UK
14,3044noradrenaline4phenylephrine4methoxamine. The consecutive curves for clonidine showed
desensitization with 3-fold rightward shift and Emax reduction of 40%. The noradrenaline curves were 4.5,
19 and 190-fold less potent after clonidine pretreatment at 105, 104 or 103 M for 10 min, respectively,
added to Emax decrease by about 20%. Clonidine (105 M for 10 min) was unable to alter the noradrena-
line curves if the treatment was made in the presence of idazoxan (α2-adrenoceptor antagonist) whereas
prazosin (α1-adrenoceptor antagonist) was ineffective. The effect of idazoxan 3107 M on noradrena-
line curves was decreased by 50% after clonidine pretreatment, as reﬂected by the concentration ratio of
5.271.2 (treated tissue) and 10.171.0 (untreated tissue). However, the concentration ratio for prazosin
3108 M was unchanged. After phenoxybenzamine (irreversible antagonist of α1-adrenoceptor)
pretreatment, the residual noradrenaline contraction was antagonized by idazoxan or prazosin with
pKB values of 7.8 and 5.1, respectively. The results indicate the presence of α2-adrenoceptors in testicular
capsule. Furthermore, these receptors may be desensitized by clonidine, causing a decreased potency of
noradrenaline.
& 2014 Published by Elsevier B.V.
1. Introduction
The testicular capsule from humans or rodents is a thin tissue
layer surrounding the testis with contractile properties which
are mainly regulated by catecholamines released from sympa-
thetic nerve endings (Bell and McLean, 1973; Campos et al., 1990;
Jurkiewicz et al., 2006). The contractile activity of testicular
capsule promotes the correct transit of the sperm out from the
seminiferous tubules to epididymis and its dysfunction can pro-
mote a decrease of male fertility (Banks et al., 2006; Qin and Lung,
2000, 2001).
The α-adrenoceptors are differentiated into α1- and α2-adreno-
ceptors and both mediate most excitatory functions in response to
the endogenous catecholamines released from sympathetic nerve
endings in several tissues, such as arteries, veins, spleen, vas
deferens and fundus of stomach (Goldberg and Robertson, 1984;
Civantos Calzada, Aleixandre de, 2001; Hermann et al., 2005;
Jurkiewicz and Jurkiewicz, 1991; Kenakin and Novak, 1988;
MacLennan et al., 1997; Molin and Bendhack, 2004).
Previous studies conducted by our laboratory showed that neuro-
nal and exogenous noradrenaline-evoked contraction in the rat testi-
cular capsule was mainly mediated by α1-adrenoceptors (Jurkiewicz
et al., 2006). However, the participation of postsynaptic α2-adreno-
ceptors was not fully investigated in the exogenous agonist-induced
contraction in rat testicular capsule.
Apart from the endogenous ligands adrenaline and noradrena-
line, several synthetic drugs are available and used to discriminate
the populations of α1- and α2-adrenoceptors. In this context,
clonidine was here chosen because it is a selective agonist of
α2-adrenoceptors (Timmermans and van Zwieten, 1981) and
widely used as antihypertensive, sedative and analgesic agent
(Arimitsu et al., 1998; Gilsbach and Hein, 2012). Clonidine is able
to induce inhibitory effects on sympathetic neurotransmission,
involving an interaction with pre-synaptic α2-adrenoceptors, or
smooth muscle contractions related to postsynaptic α1- or α2-
adrenoceptors (Caricati-Neto et al., 1995; Clark et al., 1985; Drew,
1977; Jurkiewicz and Jurkiewicz, 1991; Weiss, 1991).
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Furthermore, the long-term exposure to clonidine has been
reported to cause tolerance by desensitization of α2-adrenoceptors
(Shibata et al., 2000) and promote fertility impairment (Clark et al.,
1985; Weiss, 1991). Thus, clonidine might induce the rat testicular
capsule contraction and/or affect the exogenous catecholamine
responses in this tissue, altering the sperm transport to epididymis
and, consequently, the animal fertility.
In the present study, the pharmacological proﬁle of clonidine
(selective agonist of α2-adrenoceptors) was compared with non-
selective agonists of α-adrenoceptors (adrenaline and noradrena-
line), selective agonists of α1-adrenoceptors (phenylephrine and
methoxamine) and selective agonist of α2-adrenoceptors (UK
14,304). Moreover, we showed that the repeated exposures to
clonidine promote a decrease in its responses as well as diminish
the potency of the noradrenaline-induced contractions in rat
testicular capsule probably due to a desensitization of α2-adreno-
ceptors. These ﬁndings afford new information about the effects of
clonidine on smooth muscles, particularly in testicular capsule
which has been poorly studied and plays a signiﬁcant role in the
male fertility.
2. Material and methods
2.1. Animals and isolation of rat testicular capsule
Male (90–120 days old/ 300–400 g) Wistar rats from our own
colony (INFAR) were obtained from the Animal Facility (CEDEME)
of National Institute of Pharmacology and Molecular Biology –
UNIFESP, and maintained under controlled conditions (25 1C,
12/12 h light/dark cycle). After euthanasia by decapitation, the
rat testis were exposed and the whole testicular capsule was
carefully isolated from the tissues attachments and used for
functional experiments, as previously described (Jurkiewicz et al.,
2006).
All experimental procedures were approved by the local Ethics
Committee for de Use of Experimental Animals of Federal Uni-
versity of São Paulo (Protocol number 0016/2013) and are in
accordance with the Guide for the Care and Use of Laboratory
Animals (National Institutes of Health).
2.2. Testicular capsule preparation
The isolated testicular capsule was mounted under 1.0 g ten-
sion in a 10 ml standard organ bath containing Tyrode solution
with the following composition (mM): 137 NaCl; 5.4 KCl; 1.8 CaCl2;
1 MgCl2; 12 NaHCO3; 0.36 KH2PO4; 11 glucose, prepared in glass
distilled deionized water, bubbled with air, and maintained at
36–37 1C, pH 7.4 (Jurkiewicz et al., 2006). One end of the testicular
capsule was attached to the organ chamber, and the other end
attached by means of a silk surgical suture to a force–displacement
transducer (CB Science, mod. FT 302, USA) connected through a
bridge ampliﬁer to a PowerLab recording system (AD Instruments,
Castle Hill, Australia), coupled to a computer and the contractions
were recorded and the data stored by means of Chart v 4.2.1
software (AD Instruments, Castle Hill, Australia).
2.3. Functional experiments
2.3.1. Cumulative concentration–response curves for clonidine and
other adrenoceptors agonists
The tissues were mounted as described above and after an
equilibration period of about 40 min, cumulative concentration–
response curves for clonidine (1010 to 105 M), adrenaline
(1010 to 3106 M), noradrenaline (109 to 104 M), pheny-
lephrine (108 to 3104 M), methoxamine (106 to 102 M)
or UK 14,304 (109 to 105 M) were obtained as described
below, and these curves were used for determination of the
pharmacological parameters listed below. Then, the preparation
was carefully washed out and after 40 min of stabilization a new
cumulative concentration–response curve was performed in order
to check reproducible responses. Moreover, in some experiments
the consecutive curves for noradrenaline were performed in
the presence of cocaine 6106 M, corticosterone 105 M and
propranolol 107 M (pre-incubated for 40 min) in order to block
neuronal and extraneuronal uptake and β-adrenoceptors, respec-
tively. The curve for each agonist was performed in different
tissues of distinct animals.
2.3.2. Effects of the pretreatment with clonidine or other adrenergic
agonists in the testicular capsule contractions elicited by
noradrenaline
After a period of stabilization (40 min) of the isolation in an organ
bath, consecutive cumulative concentration–response curves for
noradrenaline (109 to 104 M) were obtained with 40 min inter-
vals. In some experiments, the testicular capsules were treated with
clonidine (105 to 103 M), noradrenaline (105 M), phenylephrine
(105 M) or UK 14,304 (105 M) for 10 min, extensively washed out,
and 40 min later, a concentration–response curve for noradrenaline
(non-selective α-adrenoceptor agonist) were constructed. Addition-
ally, the pretreatment with clonidine (105 M for 10 min) were
performed in the presence of α1- or α2-adrenoceptors antagonists
(prazosin 3108 M or idazoxan 3107 M, respectively) incu-
bated 5 min before clonidine. Thereafter, the preparation was care-
fully washed out, and after 40 min, new concentration–response
curves for noradrenaline were made. The effect of α-adrenoceptor
antagonists was also evaluated after the pretreatment with clonidine
(105 M for 10 min). Time control tissues (matched controls) were
treated in exactly the same manner but not exposed to clonidine,
noradrenaline, phenylephrine or UK 14,304. The concentration of
antagonists was chosen in accordance of pKB values reported by
literature (idazoxan: pKB 6.4 to 8.0 for α2-adrenoceptors; prazosin:
pKB 8.5 to 10 for α1-adrenoceptors) (Dabire, 1986; Halliday et al.,
1991; Oshita et al., 1993; Ramagopal and Leighton, 1989; Ruffolo
et al., 1991). In this experiment, we used the highest concentration of
prazozin (3108 M) or idazoxan (3107 M) in order to block the
clonidine effects (at 105 M) without affecting the selectivity of these
antagonists for α1- and α2-adrenoceptors, respectively.
2.3.3. Differential participation of α-adrenoceptors in the ﬁrst and
second cumulative concentration–response curves for clonidine
Cumulative concentration–response curves for clonidine (1010 to
105 M) were obtained, after a period of stabilization (40 min), in the
presence or absence of α1- or α2-adrenoceptors antagonists (prazosin
108 M or idazoxan108 M, respectively). In addition, after the ﬁrst
curve for clonidine in the absence of antagonists, the preparation was
washed out and 40 min later, new cumulative concentration–
response curves for clonidine were constructed in the absence or
presence of α1- or α2-adrenoceptors antagonists. Time control tissues
(matched control) were treated in exactly the same manner but not
exposed to any antagonist. The antagonist concentration was chosen
in accordance with pKB values described in the literature (see above,
Section 2.2.2) and the less effective concentration of prazosin or
idazoxan was used in order to calculate the pKB values of these
antagonists against the clonidine curves.
2.3.4. Effects of phenoxybenzamine pretreatment in the
noradrenaline-induced contractions on testicular capsule contraction
After initial cumulative concentration–response curve for
noradrenaline, the preparation was washed out and idazoxan
106 M was added 5 min before the addition of the irreversible
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antagonist phenoxybenzamine 3106 M and both antagonists
were maintained for 30 min (idazoxan was used to prevent an
eventual irreversible blockade of α2-adrenoceptors exerted by
phenoxybenzamine). Thereafter, the preparation was washed out
at least 10 times and 30 min later cumulative concentration–
response curves for noradrenaline were repeated. The effects of
α1- or α2-adrenoceptors antagonists were also evaluated in the
following noradrenaline-induced contraction.
2.4. Pharmacological parameters
The pharmacological parameters Emax (maximum contraction
induced by an agonist) (Jurkiewicz and Jurkiewicz, 1976) and pD2,
(apparent afﬁnity of the agonists) indicating potency, measured as
the negative log of EC50 (Jurkiewicz et al., 1977), were determined
to allow comparisons between curves of adrenergic agonists.
Moreover, the CR (EC50b/EC50a; the ratio between EC50 of the
agonist in the presence of antagonist and EC50 of the agonist in the
absence of antagonist) and the pKB (antagonist potency expressed
as the negative logarithm of the dissociation constant KB, which is
equal to the molar concentration of the antagonist divided by the
concentration-ratio minus one) (Besse and Furchgott, 1976; Neubig
et al., 2003) values were also calculated.
2.5. Data and statistical analysis
The data were calculated as a percentage of the maximum
response attained in the preparation, by using KCl 80 mM (% KCl
contraction), in general added at the end of the experiment. Curve
ﬁtting by non-linear regression for the calculation of pD2, Emax, CR
and pKB were performed with Prism v.5 software (GraphPAD
Software, San Diego, CA, U.S.A.).
Whenever appropriate, values are presented as means7S.E.M.
Paired t-tests were used for the comparisons between two groups.
A P value of less than 0.05 was considered to be statistically
signiﬁcant. The results were obtained from groups of at least four
experiments with different tissues from distinct animals.
2.6. Drugs
The following drugs were used: clonidine, noradrenaline, adrena-
line, phenylephrine, methoxamine, UK 14,304, prazosin, idazoxan and
phenoxybenzamine from Sigma Chemical Co. (St. Louis, MO, USA). All
reagents used for nutrient solutions were from Merck (Brazil).
3. Results
3.1. Cumulative concentration–response curves for clonidine and
other adrenergic agonists
Fig. 1 shows the log-concentration–response curves obtained
in rat testicular capsule in response to clonidine, noradrenaline,
adrenaline, phenylephrine and methoxamine. The order of potency
for agonists (pD2) in testicular capsule contraction was clonidine
(6.970.12; N¼5)¼adrenaline (6.970.10; N¼8)4UK 14,304
(6.570.07; N¼5)4noradrenaline (5.970.07; N¼6)4phenylephr-
ine (5.070.1; N¼7)4methoxamine (3.570.05; N¼4). However,
some differences were observed in the efﬁcacies (Emax) or intrinsic
activities of clonidine, UK 14,304 and methoxamine, which behaved
as partial agonists in relation to noradrenaline.
3.2. Effects of consecutive cumulative concentration–response curves
for clonidine
The consecutive curves for clonidine showed desensitization
as reﬂected by about 3-fold rightward shift and a 40% reduction
in Emax (Fig. 2A). However, the consecutive cumulative concentra-
tion–response curves for noradrenaline (Fig. 2B), adrenaline
(Fig. 2C), phenylephrine (Fig. 2D), methoxamine (Fig. 2E) and UK
14,304 (Fig. 2F) presented reproducible pD2 values (Table 1). Thus,
the Emax values for noradrenaline and adrenaline were slightly
increased by about 20% in the second curve (Table 1).
Additionally, consecutive cumulative concentration–response
curves for noradrenaline were performed in the presence of
cocaine 6106 M, corticosterone 105 M and propranolol 107 M
(pre-incubated for 40 min) in order to block neuronal and extra-
neuronal uptake and β-adrenoceptor, respectively. We found that
consecutive curves for noradrenaline in the presence of these
blockers presented reproducible pD2 (1st curve: 6.570.05; 2nd
curve: 6.470.04; N¼4) and Emax values (1st curve: 115.773.39;
2nd curve: 122.473.02; N¼4) (Graph not shown). These results
could indicate that the presence of uptake blockers and β-adreno-
ceptors antagonist did not affect the ability of noradrenaline to
induce reproducible responses.
3.3. Effects of the pretreatment with clonidine in the noradrenaline-
induced contraction in rat testicular capsule
In order to check whether clonidine induced desensitization in
the contractions of rat testicular capsule in response to noradrena-
line, the tissues were treated with clonidine at 105, 104 or
103 M for 10 min, carefully washed out (at least ten times), and
after 40 min of interval exposed to noradrenaline. In the tissues
pre-exposed to clonidine at 105, 104 or 103 M (for 10 min),
noradrenaline were 4.5, 19 and 190-fold, respectively, less potent
than in time controls that had been treated with vehicle (Fig. 3).
In addition, the pretreatment with clonidine decreased the Emax
for noradrenaline by about 20% (in all concentration tested for
clonidine) (Fig. 3).
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Fig. 1. Non-linear regression of the contractile responses obtained from cumulative
concentration–response curves for clonidine (Δ), adrenaline (○), noradrenaline (□),
phenylephrine (◊) methoxamine ( ) and UK 14,304 (n) expressed as a percentage
of the maximum contractile response induced by KCl 80 mM (% KCl contraction).
Values are means7S.E.M. of 4–8 independent experiments performed with tissues
from different rats. Values of pD2 and Emax are shown in Table 1.
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Fig. 2. Non-linear regression of the contractile responses obtained from consecutive cumulative concentration–response curves for clonidine (A), noradrenaline (B),
adrenaline (C), phenylephrine (D), methoxamine (E) and UK 14,304 (F) expressed as a percentage of the maximum contractile response induced by KCl 80 mM (% KCl
contraction). Values are means7S.E.M. of 6–10 independent experiments performed with tissues from different rats. nPo0.05 in relation to the Emax of the 1st curve. Values
of pD2 and Emax are shown in Table 1.
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In addition, clonidine (105 M for 10 min) did not change the
pD2 for phenylephrine (α1-adrenoceptor agonist), but the Emax was
depressed by about 50% (data not shown).
3.4. Effects of the pretreatment with noradrenaline, phenylephrine or
UK 14,304 in the noradrenaline-induced contraction in rat testicular
capsule
The testicular capsule contraction induced by noradrenaline
was also evaluated in tissues pre-exposed with noradrenaline,
phenylephrine or UK 14,304 for 10 min, extensively washed out,
and 40 min later, new curve for noradrenaline was performed.
Fig. 4 shows that pretreatment with noradrenaline, phenylephrine
or UK 14,304 (all of them at 105 M for 10 min) did not affect the
potency (pD2) or Emax of noradrenaline-induced testicular capsule
contraction, compared with time controls which were treated with
vehicle (Fig. 4).
3.5. Effects of the pretreatment with clonidine in the presence
of α-adrenoceptor antagonists on noradrenaline-induced
contraction in rat testicular capsule
The desensitization of noradrenaline curves induced by cloni-
dine (105 M for 10 min) (shown in Fig. 3) was prevented by the
α2-adrenoceptor antagonist idazoxan 3107 M (Fig. 5B) whereas
prazosin 3108 M (α1-adrenoceptor antagonist) was ineffective
(Fig. 5A), indicating that these effects depend of the α2-adreno-
ceptors activation.
3.6. Effects of α-adrenoceptor antagonists after the pretreatment
with clonidine in the noradrenaline-induced contraction in rat
testicular capsule
The effect of α-adrenoceptor antagonists on noradrenaline
curves was also evaluated after clonidine pretreatment (105 M
for 10 min) (Fig. 6). The rightward shift promoted by idazoxan
3107 M in the noradrenaline curves was decreased in 50%
after clonidine pretreatment compared with untreated tissues, as
reﬂected by the concentration ratio (CR) of 5.271.2 (treated
tissue) (Fig. 6D) and 10.171.0 (untreated tissue) (Fig. 6C). How-
ever, the CR values for prazosin 3108 M were unchanged, but
the Emax values for noradrenaline were depressed by about 40% in
treated and untreated tissues (Fig. 6A and B). On the other hand,
the Emax values for noradrenaline were increased in the presence
of idazoxan in treated tissues by about 30% (Fig. 6D).
3.7. Differential participation of α-adrenoceptor in the ﬁrst and
second cumulative concentration–response curves for clonidine
The loss of potency in the consecutive curves for clonidine and
the effect of the pretreatment of this drug in noradrenaline-
induced contraction could indicate a rapid desensitization of
α2-adrenoceptors. Therefore, both α1- and α2-adrenoceptors could
mediate the ﬁrst curve and α1-adrenoceptors could mediate the
second. In order to check this possibility, α-adrenoceptor antago-
nists were incubated before or after the ﬁrst curve for clonidine.
Prazosin 108 M was able to diminish the Emax for the ﬁrst curve of
clonidine by about 50% whereas the pD2 remained unchanged,
indicating a non-competitive antagonism (Fig. 7A). However,
idazoxan 108 M rightward shifted the ﬁrst curve for clonidine
(by about 2.5-fold, pKB¼8.1270.09; N¼5) without altering the
Emax, indicating a competitive antagonism (Fig. 7B). Surprisingly,
Table 1
Maximal contractions (% KCl contraction) and pD2 values of consecutive curves for
clonidine, noradrenaline, adrenaline, phenylephrine and methoxamine in rat
testicular capsule.
Agonists Parameters Consecutive cumulative-concentration
response curve
First curve Second curve
Clonidine (N¼10) Emax 40.072.0 17.670.8a
pD2 6.970.1 6.170.1a
Noradrenaline (N¼5) Emax 60.671.1 74.072.1a
pD2 5.670.04 5.570.05
Adrenaline (N¼8) Emax 71.371.3 82.071.5a
pD2 6.970.05 6.970.04
Phenylephrine (N¼5) Emax 55.271.5 60.271.5
pD2 5.070.1 4.670.01
Methoxamine (N¼4) Emax 51.571.8 51.172.7
pD2 3.570.05 3.470.08
UK 14,304 (N¼5) Emax 46.372.2 43.172.7
pD2 6.570.07 6.470.09
Emax (maximal contraction) expressed in % of KCl contraction and pD2 (apparent
afﬁnity of the agonists indicating potency, measured as the negative log of EC50)
obtained from the non-linear regression curves shown in Fig. 2.
a Po0.05 in relation to the ﬁrst curve. N¼number of experiments.
Fig. 3. Non-linear regression of the contractile responses obtained from cumulative concentration–response curves for noradrenaline after pretreatment with clonidine at
105 (A), 104 (B) and 103 M (C) for 10 min compared with matched control (untreated tissue with clonidine). Each point was expressed as a percentage of the maximum
contractile response induced by KCl 80 mM (% KCl contraction). Values are means7S.E.M. of 5–7 independent experiments performed with tissues from different rats.
nPo0.05 in relation to the Emax of the matched control.
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the second curve for clonidine was only rightward shifted by
prazosin 108 M (by about 5.4-fold; pKB¼8.6470.08; N¼9)
(Fig. 7C) while idazoxan 108 M only increased the Emax values
for this agonist by about 48% (Fig. 7D).
3.8. Effects of the pretreatment with phenoxybenzamine in the
noradrenaline-induced contractions
There is not information about the presence of functional
postsynaptic α2-adrenoceptors in the rat testicular capsule. The
involvement of α2-adrenoceptors in the contractions induced by
noradrenaline was studied by the pretreatment with phenoxy-
benzamine 3106 M plus idazoxan 106 M (P/I) for 30 min.
After carefully wash out, a subsequent noradrenaline curve was
constructed. The P/I treatment was able to rightward shift the
noradrenaline curves by about 5-fold and diminish the Emax in 68%.
Thus, the residual contraction was competitively antagonized by
idazoxan at 3107 M (pKB¼7.870.05; N¼5). Prazosin was also
able to rightward shift the residual contraction after phenoxyben-
zamine treatment, but only at 105 M, presenting pKB values of
5.170.11 (N¼5) (Fig. 8).
4. Discussion
In this study, we reported that the rat testicular capsule
contracts in response to clonidine, but this response is decreased
with consecutive curves for this agonist. Moreover, the rat TC
pretreatment with clonidine also diminished the potency of the
noradrenaline-induced contractions. The probable involvement of
α2-adrenoceptors in these effects was discussed below.
In addition, we have shown that the rat testicular capsule is able
to contract in response to non-selective adrenergic agonists such as
noradrenaline or adrenaline, as reported by previous presentations
(Davis and Horowitz, 1978, 1979; Davis and Langford, 1969a, 1969b;
Fig. 4. Non-linear regression of the contractile responses obtained from cumulative concentration–response curves for noradrenaline after pretreatment with noradrenaline
(A), phenylephrine (B) and UK 14,304 (C) at 105 M for 10 min compared with matched control (untreated tissue with agonists). Each point was expressed as a percentage of
the maximum contractile response induced by KCl 80 mM (% KCl contraction). Values are means7S.E.M. of 5 independent experiments performed with tissues from
different rats.
Fig. 5. Non-linear regression of the contractile responses obtained from cumulative concentration–response curves for noradrenaline after pretreatment with clonidine
performed in the presence of prazosin (A) or idazoxan (B). Each point was expressed as a percentage of the maximum contractile response induced by KCl 80 mM (% KCl
contraction). Values are means7S.E.M. of 5 independent experiments performed with tissues from different rats. nPo0.05 in relation to the Emax of the matched control
(untreated tissue with clonidine, but incubated with antagonists).
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Jurkiewicz et al., 2006). However, the effects of clonidine, α2-
adrenoceptor agonist, were still not completely evaluated.
Clonidine is considered a selective α2-adrenoceptors agonist
with a partial agonist effect on α1-adrenoceptors (Timmermans
and van Zwieten, 1981). The activation of pre-synaptic α2-adreno-
ceptors by clonidine is able to induce a decrease of sympathetic
activity whereas the interaction of postsynaptic α2-adrenoceptors
promotes contraction of smooth muscles, such as saphenous veins,
arterioles or venules from human or rodents (Civantos Calzada,
Aleixandre de, 2001; Molin and Bendhack, 2004). However, post-
synaptic α1-adrenoceptors are also related to the contractile effects
of clonidine in aorta (Molin and Bendhack, 2004), anococcygeus
muscle (Uzbay and Onur, 1993) and vas deferens (Takeuchi et al.,
1987) from rodents.
The contractile proﬁle of clonidine in rat testicular capsule was
determined by pharmacological parameters (pD2 and Emax) and
compared with other adrenergic agonist. Fig. 1 shows a high
potency (pD2) for clonidine, adrenaline and UK 14,304 which
present higher afﬁnity for α2-adrenoceptors than α1-adrenoceptors
(Bylund et al., 1992; Goldberg and Robertson, 1984), whereas
phenylephrine and methoxamine, which are considered as
selective agonists for α1-adrenoceptors, presented low potency
(90 and 2500-fold, respectively, lower than clonidine or adrena-
line) (Minneman et al., 1994).
In addition, clonidine produced a much smaller contractile
response (Emax) compared with adrenaline and noradrenaline,
and therefore, this drug could be classiﬁed as partial agonist.
Accordingly, it has been described that clonidine acts as partial
agonist of α1- and α2-adrenoceptors with α1/α2 receptor selectivity
of approximately 1:200 (Zhao et al., 2008).
The repeated exposure to clonidine in rat testicular capsule led
to diminished responses (desensitization, as previously deﬁned by
Neubig et al., 2003) as reﬂected by the decreased values of pD2 and
Emax with consecutive curves (Fig. 2A, Table 1). However, repeated
Fig. 6. The panels A and C present the non-linear regression of the contractile responses obtained from cumulative concentration–response curves for noradrenaline in the
absence (matched control) or the presence of prazosin (A) or idazoxan (C). The panels B and D show the non-linear regression of the contractile responses obtained from
cumulative concentration–response curves for noradrenaline after pretreatment clonidine and in the absence or presence of prazosin (B) or idazoxan (D). Each point was
expressed as a percentage of the maximum contractile response induced by KCl 80 mM (% KCl contraction). Values are means7S.E.M. of 5 independent experiments
performed with tissues from different rats. nPo0.05 in relation to the Emax of the matched control (A and D) (untreated tissue with clonidine, but incubated with antagonists)
or clonidine treated tissues without subsequent incubation of antagonists (B and C).
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exposure of testicular capsule with noradrenaline (α-adrenoceptor
agonist), adrenaline (α-adrenoceptor agonist), phenylephrine
(selective α1-adrenoceptor agonist) or methoxamine (selective
α1-adrenoceptor agonist) presented reproducible responses,
except the Emax values for noradrenaline and adrenaline which
were slightly increased at the second curve (Fig. 2, Table 1).
In addition, noradrenaline only presented diminished responses
(pD2 and Emax) when previously exposed to clonidine (Fig. 3),
but not to noradrenaline, phenylephrine or UK 14,304 (selective
α2-adrenoceptor agonist) (Fig. 4). The same effects of clonidine
were observed in rat spleen and distal portion of epididymis, both
presenting populations of postsynaptic α1- and α2-adrenoceptors
(Haynes and Hill, 1996; Kenakin and Novak, 1988), but not in
vas deferens (present postsynaptic α1-adrenoceptors (Campos
et al., 2003; von Asmuth et al., 1991) (Silva-Junior, unpublished
observations).
The noradrenaline curves conducted in the presence of uptake
system inhibitors and β-adrenoceptors antagonist were potentiated by
about 10-fold (pD2) and the Emax values almost doubled, comparing
the pharmacological parameters from this experiment (Section 3.2) to
those shown in Table 1 (noradrenaline curves performed in the
absence of uptake system inhibitors and β-adrenoceptors antagonist).
Further, we also found that the consecutive curves for noradrenaline in
the presence of these blockers presented reproducible responses
(Section 3.2). However, it is important to mention that the presence
of the uptake blockers and β-adrenoceptors antagonist could also
affect the pharmacological parameters of the other adrenoceptors
agonists used in this study as well as their ability to induce desensit-
ization of the rat testicular capsule contraction.
Several studies indicate that UK 14,304 induces desensitization
of α2-adrenoceptor in cultured cells (Boehm et al., 1995; Gasic and
Green, 1995). However, the inability of UK 14,304 to induce
desensitization of noradrenaline curves in our work might be
related to: (a) the short period of the incubation (10 min) used;
(b) the subtype of α2-adrenoceptors presents in the rat testicular
capsule; or (c) speciﬁc mechanisms related to the tissue studied.
The noradrenaline responses showed a decreased Emax values
in the tissues pre-exposed with clonidine (Fig. 3). We speculate
Fig. 7. Non-linear regression of the consecutive contractile responses obtained from cumulative concentration–response curves for clonidine in the absence (matched
control) or presence of prazosin and idazoxan. The panels show the effects of prazosin or idazoxan in the ﬁrst (A and B) or second curves (C and D) for clonidine. Each point
was expressed as a percentage of the maximum contractile response induced by KCl 80 mM (% KCl contraction). Values are means7S.E.M. of 5–10 independent experiments
performed with tissues from different rats. nPo0.05 in relation to the Emax of the matched control (in the absence of antagonists).
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that clonidine at high concentrations could activate other
α2-adrenoceptor signaling pathway which would avoid the max-
imum development of tension for noradrenaline, such as stimula-
tion of adenylyl cyclase or nitric oxide generation (Eason et al.,
1992; Zhao et al., 2008). However, this hypothesis needs further
investigations because the activation of these additional signaling
pathways has only been observed to date in heterologous systems
where α2-adrenoceptors are expressed at relatively high density.
The reduction of noradrenaline potency induced by the pretreat-
ment with clonidine in rat testicular capsule was only prevented by
idazoxan, indicating that these effects were related with the activation
of α2-adrenoceptors. Additionally, the rightward shift by idazoxan in
the noradrenaline contractions was drastically reduced if the tissues
were pre-exposed to clonidine, reﬂecting a possible decrease in the
functional α2-adrenoceptors in this tissue. The desensitization of α2-
adrenoceptors was reported by several studies using cell culture
system and most of them used noradrenaline or adrenaline for
30 min as a tool to induce desensitization (Daunt et al., 1997; Eason
and Liggett, 1993; Liang et al., 1998; Liggett et al., 1992). In our study,
we demonstrated that clonidine was able to induce desensitization at
a short time and in a functional model.
Notwithstanding its role as a clinical agent candidate, our results
indicate a complex participation of α-adrenergic receptor in the
clonidine-induced contractions in rat testicular capsule. The ﬁrst curve
for clonidine appears to be mediated by α1- and α2-adrenoceptors
while the second curve seems to be mediated by α1-adrenoceptors.
The pKB values of idazoxan against the ﬁrst curve for clonidine (8.12)
were compatible with those reported in human platelet α2-adreno-
ceptors (8.04) (Connaughton and Docherty, 1990) and pre-synaptic α2-
adrenoceptors in rat vas deferens (8.70) (Doxey et al., 1984). Thus,
prazosin pKB values against the second curve for clonidine (pKB 8.64)
are also similar for α1-adrenoceptors in rat anococcygeus muscle (pKB
8.43) (Adenekan and Tayo, 1982) and small mesenteric vein (pKB 8.5)
(Stam et al., 1999). Therefore, the differential activation of these
receptors in the consecutive curves for clonidine may be due to a
rapid desensitization of α2-adrenoceptors. Additionally, we found that
the Emax for noradrenaline after the pretreatment with clonidine
(Fig. 6D) and the second curve for clonidine (Fig. 7D) were increased
in the presence of idazoxan. The exact mechanisms related to these
effects are unknown and need further investigation.
The presence of functional α2-adrenoceptors was still not
reported in rat testicular capsule. Previous study from our labora-
tory indicated that noradrenaline-induced contraction in isolated
rat testicular capsule was mainly mediated by α1-adrenoceptors
(Jurkiewicz et al., 2006). However, the Schild slopes (different from
one unity) for α-adrenoceptor antagonists (Jurkiewicz et al., 2006)
and the resistant responses after phenoxybenzamine pretreatment
(Fig. 8) strongly indicate the participation of other α-adrenoceptor
in the noradrenaline-induced contractions. In fact, the residual
noradrenaline contraction of rat testicular capsule after irreversible
blockade of α1-adrenoceptors induced by phenoxybenzamine was
antagonized by idazoxan, showing pKB values (7.8) compatible with
those reported for its interaction with α2-adrenoceptors (Kenakin
and Novak, 1988; MacLennan et al., 1997). In addition, the low
pKB values for prazosin (5.1) against noradrenaline curves after
phenoxybenzamine pretreatment is consistent to those reported
for α2-adrenoceptors induced contraction in smooth muscle
(MacLennan et al., 1997). Altogether, these results might indicate
the participation of functional α1- and α2-adrenoceptors in the
noradrenaline induced contraction in rat testicular capsule.
Further evidence for distinct populations of α1- and α2-adreno-
ceptor in rat testicular capsule is also provided by (1) a non-
competitive effect of prazosin against noradrenaline and clonidine
curves (ﬁrst curve – Figs. 6A, and 7A), (2) a competitive effect of this
antagonist in the second curve for clonidine (Fig. 7C) and (3) unal-
tered Emax values of noradrenaline curves in the presence of
prazosin after pretreatment with phenoxybenzamine (Fig. 8B).
Similar results are described by Daly et al. (1988) and Ohlstein
et al. (1989) which showed that prazosin produced a nonparallel
rightward shift in the noradrenaline concentration–response curves
with a marked depression in the maximal response, indicating
noncompetitive antagonism as consequence of two distinctive
adrenoceptors (α1- and α2-adrenoceptors) mediating the same
contractile response (Daly et al., 1988; Ohlstein et al., 1989).
It is well established that the motor activity of testicular capsule
is essential for the correct transport of sperm from seminiferous
tubule to epididymis, and therefore, playing a signiﬁcant role in the
animal fertility. The clinical use of clonidine is related to male fertility
disorders mainly due to its action in the central nervous system
(Beeley, 1984; Clark et al., 1985; Srilatha et al., 1999; Weiss, 1991).
Fig. 8. Non-linear regression of the contractile responses obtained from cumulative concentration–response curves for noradrenaline before and after the pretreatment with
phenoxybenzamine plus idazoxan (P/I) (idazoxan was used to prevent the collateral irreversible blockade of α2-adrenoceptors exerted by phenoxybenzamine) (A and B). The
panels A and B show the effect of idazoxan (A) or prazosin (B) in the residual contraction after P/I treatment. Each point was expressed as a percentage of the maximum
contractile response induced by KCl 80 mM (% KCl contraction). Values are means7S.E.M. of 5 independent experiments performed with tissues from different rats.
nPo0.05 in relation to the Emax of the control curve.
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However, this is the ﬁrst report that shows an impairment of
noradrenaline-elicited contractions induced by clonidine in rat testi-
cular capsule which presumably could affect the correct transport of
non-motile spermatozoa from seminiferous tubule out of the testis.
5. Conclusion
In conclusion, our data indicate that clonidine induces con-
traction in rat testicular capsule and the involvement of functional
α2-adrenoceptors may be considered. Furthermore, clonidine may
promote desensitization of functional α2-adrenoceptors which
could participate in the noradrenaline-induced contractions. The
subtypes of α2-adrenoceptor as well as the signaling pathway
related to these effects remain open to investigations.
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